Navigation Links
Pharmacopeia Assists the World Health Organization in the Discovery of Novel Therapeutics for the Treatment of Malaria
Date:8/27/2007

Princeton, N.J., Aug. 27 /PRNewswire-FirstCall/ -- Pharmacopeia (Nasdaq: PCOP), an innovator in the discovery and development of novel small molecule therapeutics, announced today that the company will assist the World Health Organization's Special Program for Research and Training in Tropical Diseases (WHO/TDR) in its efforts to develop novel antimalarial agents. Pharmacopeia will receive funding to conduct medicinal chemistry research on compounds identified through WHO/TDR's drug screening program involving a network of centers in developed and developing countries. The goal of this project is to identify new lead series with the potential to become novel malaria drug candidates. Malaria kills more than one million people a year, with most of those being children in the developing world.

For more information about Pharmacopeia, please visit http://www.pharmacopeia.com.

Contact:

Amy Sharpless

609-452-3643

ir_pr@pcop.com


'/>"/>
SOURCE Pharmacopeia
Copyright©2007 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Pharmacopeia Announces Positive Results from Initial DARA Clinical Trial
2. Suven Life Sciences Presenting Pre-clinical data of their NCE’s SUVN-502 and SUVN-507at International Brain Research Organization (IBRO) 2007 World Congress of Neuroscience
3. MAP Pharmaceuticals to Present Unit Dose Budesonide Phase 2 Clinical Data at the World Asthma Meeting
4. Active Biotech presents new pre-clinical data for the 57-57 project at the 8th World Congress on Inflammation
5. New Study Suggests Better Patient Outcomes with CYPHER Sirolimus-Eluting Coronary Stent than with Taxus Stent in Real-World Clinical Settings
6. World First Medical Treatment Announced by Researchers at Queen Mary University London and University of Leicester
7. Abbott Announces Positive Nine-Month Results From the Worlds First Clinical Trial of a Fully Bioabsorbable Drug Eluting Coronary Stent
8. ARRIVE Registry Analysis Identifies Predictors of Stent Thrombosis in Real-World Use of Drug-Eluting Stents
9. Gentiums Defibrotide Highlighted in Poster Presentation at World Congress of Nephrology
10. Onconase has Potential as Chemopreventive Agent in Mesothelioma, Reports World-Renowned Mesothelioma Researcher at AACR Annual Meeting
11. Ace Biosciences, Ace393, the Worlds First Commercial Vaccine for Travellers Diarrhoea Caused by Campylobacter Successfully Completes Phase I Clinical Trials
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/10/2019)... ... 2019 , ... Mindray, a leading developer of next-generation medical ... a modular, state-of-the-art family of anesthesia solutions. The new series includes the ... to perioperative care. , “The recently launched Advantage platform further enhances Mindray’s ...
(Date:1/10/2019)... ... 10, 2019 , ... Pelican BioThermal , the global ... under the leadership of Dominic Hyde, vice president of Credo™ on Demand. , ... shipper rental program allowing organizations to choose the shipper application that best fits ...
(Date:1/8/2019)... ... January 08, 2019 , ... University Hospitals ... UroLift® Center of Excellence. The designation recognizes that Dr. Jaeger has achieved a ... commitment to exemplary care for men suffering from symptoms associated with benign prostatic ...
Breaking Medicine Technology:
(Date:1/13/2019)... (PRWEB) , ... January 12, 2019 , ... ... Professionals Committee (YPC) in conjunction with Temple University hosted a continuing education (CEU) ... and Mentees. The event aimed to create a series of talks to ...
(Date:1/13/2019)... (PRWEB) , ... January 13, 2019 , ... Dr. Christine ... of her book, "Gut Check: How The Broken Medical Model Is Creating More Sickness ... discusses the biggest obstacles impeding our health...Symptoms. Dr. Christine explains that judging our ...
(Date:1/11/2019)... , ... January 11, 2019 , ... ... three finalist teams in its “Next Generation Captive Insurance Solutions for New Risk ... Risk Solutions. , The three finalist teams are: , ...
(Date:1/11/2019)... ... , ... Women’s Excellence Obstetrics and Gynecology announces an exciting ... of Women’s Excellence, will co-host WJR’s "Health Women Show" with WJR’s Marie Osborne ... , "We are excited to partner with a longstanding, reputable organization like WJR ...
(Date:1/10/2019)... ... January 10, 2019 , ... Mount Sinai Health System is ... the United Nations Staff Recreation Council in support of the Helen Sawaya Fund, ... including music, art, massage, and pet therapies to increase the comfort and emotional ...
Breaking Medicine News(10 mins):